Effects of SGLT2 Inhibitors on Atherosclerosis: Lessons from Cardiovascular Clinical Outcomes in Type 2 Diabetic Patients and Basic Researches

Atherosclerosis-caused cardiovascular diseases (CVD) are the leading cause of mortality in type 2 diabetes mellitus (T2DM). Sodium-glucose cotransporter 2 (SGLT2) inhibitors are effective oral drugs for the treatment of T2DM patients. Multiple pre-clinical and clinical studies have indicated that SG...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jing, Hirai, Taro, Koya, Daisuke, Kitada, Munehiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745121/
https://www.ncbi.nlm.nih.gov/pubmed/35011882
http://dx.doi.org/10.3390/jcm11010137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745121/
https://www.ncbi.nlm.nih.gov/pubmed/35011882
http://dx.doi.org/10.3390/jcm11010137

Ejemplares similares